
In a recent assessment as of August 25, 2025, Motley Fool's Stock Advisor did not include Teladoc Health (NYSE: TDOC) among its top 10 recommended stocks, despite discussing the company. The article, largely promotional for the advisory service's subscription, emphasizes its historical market-beating returns to highlight the value of its exclusive stock picks.
As of August 25, 2025, Teladoc Health (TDOC) was notably excluded from the Motley Fool Stock Advisor's list of its top 10 recommended stocks. This explicit omission is a significant data point, reflected in the negative per-ticker sentiment score of -0.2, suggesting a lack of high conviction from the influential advisory service despite the company being a subject of their analysis. The article itself is primarily a promotional vehicle for the Stock Advisor subscription, highlighting historical successes with Nvidia and Netflix to emphasize the value of its exclusive picks. A conflicting signal arises from the disclosure that The Motley Fool itself, along with some of its named analysts, holds positions in TDOC. This suggests that while the stock does not meet the criteria for their highest-conviction 'buy now' list, it may be viewed internally as a long-term hold or a holding with a different risk-return profile. The overall market impact is rated low at 0.3, indicating this opinion is more likely to influence retail sentiment than trigger significant institutional capital movement.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment